Search details
1.
Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects.
Immunity
; 45(4): 931-943, 2016 10 18.
Article
in English
| MEDLINE | ID: mdl-27717798
2.
MXD3 antisense oligonucleotide with superparamagnetic iron oxide nanoparticles: A new targeted approach for neuroblastoma.
Nanomedicine
; 24: 102127, 2020 02.
Article
in English
| MEDLINE | ID: mdl-31783139
3.
Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016.
J Transl Med
; 15(1): 236, 2017 11 16.
Article
in English
| MEDLINE | ID: mdl-29145885
4.
Novel targeted therapy for neuroblastoma: silencing the MXD3 gene using siRNA.
Pediatr Res
; 82(3): 527-535, 2017 Sep.
Article
in English
| MEDLINE | ID: mdl-28419087
5.
Novel Targeted Therapy for Precursor B Cell Acute Lymphoblastic Leukemia: anti-CD22 Antibody-MXD3 Antisense Oligonucleotide Conjugate.
Mol Med
; 22: 632-642, 2016 Oct.
Article
in English
| MEDLINE | ID: mdl-27455414
6.
Loss of MXD3 induces apoptosis of Reh human precursor B acute lymphoblastic leukemia cells.
Blood Cells Mol Dis
; 54(4): 329-35, 2015 Apr.
Article
in English
| MEDLINE | ID: mdl-25554682
7.
Tissues in different anatomical sites can sculpt and vary the tumor microenvironment to affect responses to therapy.
Mol Ther
; 22(1): 18-27, 2014 Jan.
Article
in English
| MEDLINE | ID: mdl-24048441
8.
Targeted therapy with MXD3 siRNA, anti-CD22 antibody and nanoparticles for precursor B-cell acute lymphoblastic leukaemia.
Br J Haematol
; 167(4): 487-99, 2014 Nov.
Article
in English
| MEDLINE | ID: mdl-25196579
9.
Autoimmunity associated with immunotherapy of cancer.
Blood
; 118(3): 499-509, 2011 Jul 21.
Article
in English
| MEDLINE | ID: mdl-21531979
10.
A distinct subpopulation of leukemia initiating cells in acute precursor B lymphoblastic leukemia: quiescent phenotype and unique transcriptomic profile.
Front Oncol
; 12: 972323, 2022.
Article
in English
| MEDLINE | ID: mdl-36212452
11.
Cancer Induces a Stress Ileopathy Depending on ß-Adrenergic Receptors and Promoting Dysbiosis that Contributes to Carcinogenesis.
Cancer Discov
; 12(4): 1128-1151, 2022 04 01.
Article
in English
| MEDLINE | ID: mdl-34930787
12.
Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade.
Nat Med
; 27(8): 1432-1441, 2021 08.
Article
in English
| MEDLINE | ID: mdl-34239137
13.
Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients.
Eur Urol
; 78(2): 195-206, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32376136
14.
Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage.
Science
; 369(6506): 936-942, 2020 08 21.
Article
in English
| MEDLINE | ID: mdl-32820119
15.
Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer.
Nat Med
; 26(6): 919-931, 2020 06.
Article
in English
| MEDLINE | ID: mdl-32451498
16.
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade.
Cell Res
; 29(10): 846-861, 2019 Oct.
Article
in English
| MEDLINE | ID: mdl-31481761
17.
Targeting Chemokines and Chemokine Receptors in Melanoma and Other Cancers.
Front Immunol
; 9: 2480, 2018.
Article
in English
| MEDLINE | ID: mdl-30420855
18.
TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer.
Oncoimmunology
; 7(12): e1386826, 2018.
Article
in English
| MEDLINE | ID: mdl-30524877
19.
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.
Science
; 359(6371): 91-97, 2018 Jan 05.
Article
in English
| MEDLINE | ID: mdl-29097494
20.
Immune biomarkers for prognosis and prediction of responses to immune checkpoint blockade in cutaneous melanoma.
Oncoimmunology
; 6(8): e1299303, 2017.
Article
in English
| MEDLINE | ID: mdl-28919986